Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Study:

A Study of Neurocognitive Function in Children Treated for ALL

Rationale:

Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.

Purpose:

This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia.

Study Status: Recruiting

Recruiting:
Clinical Trials Office - Cleveland Clinic Taussig Cancer Cente 866-223-8100

Condition Intervention Phase
Cognitive/Functional Effects
Leukemia
Long-term Effects Secondary to Cancer Therapy in Children
Neurotoxicity
Psychosocial Effects of Cancer and Its Treatment
Genetic: microarray analysis
Genetic: polymorphism analysis
Other: laboratory biomarker analysis
Other: pharmacological study
Procedure: cognitive assessment
Procedure: diffusion tensor imaging
Procedure: management of therapy complications
Procedure: psychosocial assessment and care
N/A

Verified by Children`s Oncology Group April, 2011

Sponsored by: Children`s Oncology Group
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov identifier: NCT00437060

Study Type: Interventional

Study Design: N/A

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States

Naomi J. Winick, MD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site